BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 28028983)

  • 1. Monitoring of Circulating Tumor Cells by a Combination of Immunomagnetic Enrichment and RT-PCR in Colorectal Cancer Patients Undergoing Surgery.
    Vojtechova G; Benesova L; Belsanova B; Minarikova P; Levy M; Lipska L; Suchanek S; Zavoral M; Minarik M
    Adv Clin Exp Med; 2016; 25(6):1273-1279. PubMed ID: 28028983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monitoring of circulating tumor cells in patients undergoing surgery for hepatic metastases from colorectal cancer.
    Pesta M; Fichtl J; Kulda V; Topolcan O; Treska V
    Anticancer Res; 2013 May; 33(5):2239-43. PubMed ID: 23645782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heterogeneous detection of circulating tumor cells in patients with colorectal cancer by immunomagnetic enrichment using different EpCAM-specific antibodies.
    Antolovic D; Galindo L; Carstens A; Rahbari N; Büchler MW; Weitz J; Koch M
    BMC Biotechnol; 2010 Apr; 10():35. PubMed ID: 20426872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined use of positive and negative immunomagnetic isolation followed by real-time RT-PCR for detection of the circulating tumor cells in patients with colorectal cancers.
    Guo J; Xiao B; Zhang X; Jin Z; Chen J; Qin L; Mao X; Shen G; Chen H; Liu Z
    J Mol Med (Berl); 2004 Nov; 82(11):768-74. PubMed ID: 15490093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of circulating tumor cells with CK20 RT-PCR is an independent negative prognostic marker in colon cancer patients - a prospective study.
    Hinz S; Hendricks A; Wittig A; Schafmayer C; Tepel J; Kalthoff H; Becker T; Röder C
    BMC Cancer; 2017 Jan; 17(1):53. PubMed ID: 28086834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of cytokeratin 20 mRNA in the peripheral blood of patients with colorectal cancer by immunomagnetic bead enrichment and real-time reverse transcriptase-polymeras chain reaction.
    Guo J; Xiao B; Jin Z; Qin L; Chen J; Chen H; Zhang X; Liu Z
    J Gastroenterol Hepatol; 2005 Aug; 20(8):1279-84. PubMed ID: 16048578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical significance of enrichment and detection of circulating tumor cells in NSCLC patients with immunomagnetic beads].
    Huang TH; Wang Z; Li Q; Li FR; Qi H; Zhou HX
    Zhonghua Zhong Liu Za Zhi; 2007 Sep; 29(9):676-80. PubMed ID: 18246797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor-associated gene expression in disseminated tumor cells correlates with disease progression and tumor stage in colorectal cancer.
    Zieglschmid V; Hollmann C; Mannel J; Albert W; Jaeschke-Melli S; Eckstein B; Hillemann T; Greten TF; Gross E; Böcher O
    Anticancer Res; 2007; 27(4A):1823-32. PubMed ID: 17649779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of immunomagnetic cell enrichment in combination with RT-PCR for the detection of rare circulating head and neck tumor cells in human peripheral blood.
    Tong X; Yang L; Lang JC; Zborowski M; Chalmers JJ
    Cytometry B Clin Cytom; 2007 Sep; 72(5):310-23. PubMed ID: 17205568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating tumor cells in metastatic colorectal cancer: efficacy and feasibility of different enrichment methods.
    Königsberg R; Gneist M; Jahn-Kuch D; Pfeiler G; Hager G; Hudec M; Dittrich C; Zeillinger R
    Cancer Lett; 2010 Jul; 293(1):117-23. PubMed ID: 20167419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating tumor cells in patients with breast cancer: monitoring chemotherapy success.
    Ušiaková Z; Mikulová V; Pintérová D; Brychta M; Valchář J; Kubecová M; Tesařová P; Bobek V; Kološtová K
    In Vivo; 2014; 28(4):605-14. PubMed ID: 24982230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a molecular multimarker assay for the analysis of circulating tumor cells in adenocarcinoma patients.
    de Albuquerque A; Kubisch I; Ernst D; Breier G; Stamminger G; Fersis N; Stölzel U; Boese-Landgraf J; Eichler A; Kaul S
    Clin Lab; 2012; 58(5-6):373-84. PubMed ID: 22783565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating tumor cell microseparator based on lateral magnetophoresis and immunomagnetic nanobeads.
    Kim S; Han SI; Park MJ; Jeon CW; Joo YD; Choi IH; Han KH
    Anal Chem; 2013 Mar; 85(5):2779-86. PubMed ID: 23384087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of three distinct methods for the detection of circulating tumor cells in colorectal cancer patients.
    Gervasoni A; Sandri MT; Nascimbeni R; Zorzino L; Cassatella MC; Baglioni L; Panigara S; Gervasi M; Di Lorenzo D; Parolini O
    Oncol Rep; 2011 Jun; 25(6):1669-703. PubMed ID: 21455578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of blood-borne cells in colorectal cancer patients by nested reverse transcription-polymerase chain reaction for carcinoembryonic antigen messenger RNA: longitudinal analyses and demonstration of its potential importance as an adjunct to multiple serum markers.
    Guadagni F; Kantor J; Aloe S; Carone MD; Spila A; D'Alessandro R; Abbolito MR; Cosimelli M; Graziano F; Carboni F; Carlini S; Perri P; Sciarretta F; Greiner JW; Kashmiri SV; Steinberg SM; Roselli M; Schlom J
    Cancer Res; 2001 Mar; 61(6):2523-32. PubMed ID: 11289125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Highly sensitive detection and mutational analysis of lung cancer circulating tumor cells using integrated combined immunomagnetic beads with a droplet digital PCR chip.
    Gao W; Huang T; Yuan H; Yang J; Jin Q; Jia C; Mao G; Zhao J
    Talanta; 2018 Aug; 185():229-236. PubMed ID: 29759193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased detection of circulating tumor cells in the blood of colorectal carcinoma patients using two reverse transcription-PCR assays and multiple blood samples.
    Wharton RQ; Jonas SK; Glover C; Khan ZA; Klokouzas A; Quinn H; Henry M; Allen-Mersh TG
    Clin Cancer Res; 1999 Dec; 5(12):4158-63. PubMed ID: 10632355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic and predictive value of circulating tumor cell analysis in colorectal cancer patients.
    de Albuquerque A; Kubisch I; Stölzel U; Ernst D; Boese-Landgraf J; Breier G; Stamminger G; Fersis N; Kaul S
    J Transl Med; 2012 Nov; 10():222. PubMed ID: 23146106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of circulating tumor cells in breast cancer with a refined immunomagnetic nanoparticle enriched assay and nested-RT-PCR.
    Li FR; Li Q; Zhou HX; Qi H; Deng CY
    Nanomedicine; 2013 Oct; 9(7):1106-13. PubMed ID: 23506951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A multimarker panel for circulating tumor cells detection predicts patient outcome and therapy response in metastatic colorectal cancer.
    Barbazán J; Muinelo-Romay L; Vieito M; Candamio S; Díaz-López A; Cano A; Gómez-Tato A; Casares de Cal Mde L; Abal M; López-López R
    Int J Cancer; 2014 Dec; 135(11):2633-43. PubMed ID: 24752533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.